Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25294584 | 0.85 | CA1 (0.30) | — | |
| SCHEMBL25255398 | 0.81 | ALDH1A1 (0.32) | MAPTSMN1; SMN2 | |
| SCHEMBL28582202 | 0.78 | FAAH (0.39) | — | |
| SCHEMBL27930100 | 0.73 | SMN1; SMN2 (0.35) | SMN1; SMN2 | |
| SCHEMBL29206586 | 0.68 | — | — | |
| SCHEMBL361494 | 0.66 | — | — | |
| SCHEMBL25297672 | 0.65 | FAAH (0.33) | MAPTSMN1; SMN2 | |
| SCHEMBL2321357 | 0.65 | — | — | |
| SCHEMBL25298936 | 0.64 | NPC1 (0.35) | MAPTSMN1; SMN2 | |
| SCHEMBL14336083 | 0.64 | MAPT (0.38) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12171785-B2 | Pluripotent cells derived from bone marrow and methods for isolation | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2024-12-24 | — | — | US | disclosed |
| US-20230302058-A1 | TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS | CELULARITY INC. (US) | 2023-09-28 | — | — | US | disclosed |
| WO-2023149262-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | 関西ペイント株式会社 | 2023-08-10 | — | — | WO | disclosed |
| WO-2023149261-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | 関西ペイント株式会社 | 2023-08-10 | — | — | WO | disclosed |
| US-11197889-B2 | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof | ABT HOLDING COMPANY (US) | 2021-12-14 | — | — | US | disclosed |
| US-20210346429-A1 | IMMUNOMODULATORY PROPERTIES OF MULTIPOTENT ADULT PROGENITOR CELLS AND USES THEREOF | ABT HOLDING COMPANY (US) | 2021-11-11 | — | — | US | disclosed |
| US-20210230537-A1 | ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS | CELULARITY INC. (US) | 2021-07-29 | — | — | US | disclosed |
| US-10870834-B2 | Isolated populations of adult renal cells and methods of isolating and using same | TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. (IL) | 2020-12-22 | — | — | US | disclosed |
| US-20190314424-A1 | TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS | Celularity, Inc. (US) | 2019-10-17 | — | — | US | disclosed |
| EP-3548051-A1 | TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS | Celularity, Inc. (US) | 2019-10-09 | — | — | EP | disclosed |
| US-20060008450-A1 | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2006-01-12 | — | — | US | disclosed |
| WO-2005112959-A2 | USE OF UMBILICAL CORD BLOOD STEM CELLS TO TREAT ISCHEMIC EVENT | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2005-12-01 | — | — | WO | disclosed |
| WO-2005113748-A2 | MAPC GENERATION OF LUNG TISSUE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20050181502-A1 | Multipotent adult stem cells and methods for isolation | ATHERSYS, INC. (US) | 2005-08-18 | — | — | US | disclosed |
| WO-2005021738-A1 | KIDNEY DERIVED STEM CELLS AND METHODS FOR THEIR ISOLATION, DIFFERENTIATION AND USE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2005-03-10 | — | — | WO | disclosed |
| EP-1226233-A2 | MULTIPOTENT ADULT STEM CELLS AND METHODS FOR ISOLATION | MCL LLC (US) | 2002-07-31 | — | — | EP | disclosed |
| WO-2001011011-A9 | MULTIPOTENT ADULT STEM CELLS AND METHODS FOR ISOLATION | MCL LLC (US) | 2002-07-25 | — | — | WO | disclosed |
| US-6274748-B1 | MIXING FATTY ACID WITH AN AMINO OXY ALKANE; HEATING; DEHYDRATION | ZENITH COSMETIC TECHNOLOGIES LLC | 2001-08-14 | — | — | US | disclosed |
| WO-2001045503-A2 | CRYOPRESERVATION COMPOSITIONS AND METHODS FOR PERIPHERAL BLOOD LYMPHOCYTES | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2001-06-28 | — | — | WO | disclosed |
| WO-2001011011-A2 | MULTIPOTENT ADULT STEM CELLS AND METHODS FOR ISOLATION | MCL LLC (US) | 2001-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210230537-A1 | ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS | PGF, FLT4, FLT1 | MAPT 4870/4885SMN1; SMN2 4808/4885 |
| US-20190314424-A1 | TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS | PGF, CDH1, CXCL12 | MAPT 3917/4885SMN1; SMN2 3550/4885 |
| US-20230302058-A1 | TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS | PGF, CDH1, CXCL12 | MAPT 3917/4885SMN1; SMN2 3550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.